HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wella dispute

This article was originally published in The Rose Sheet

Executive Summary

Wella minority shareholders propose adding a resolution to Wella's May 13 annual general meeting agenda that requests appointment of a special representative to seek damages from Procter & Gamble. Minority group claims P&G violated German takeover law by not signing a domination agreement with Wella before completing a worldwide licensing agreement for Wella consumer products. Shareholders additionally are seeking a resolution barring P&G from voting at the meeting. Resolution request is the latest effort by the group to thwart the integration of Wella into P&G. They previously filed a lawsuit in Darmstadt, Germany to block the licensing agreement (1"The Rose Sheet" March 8, 2004, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS012045

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel